Hunan Hansen Pharmaceutical Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 235.387 million compared to CNY 174.351 million a year ago. Operating income was CNY 51.782 million compared to CNY 43.015 million a year ago. Net income was CNY 45.731 million compared to CNY 36.943 million a year ago. Basic earnings per share from continuing operations was CNY 0.0909 compared to CNY 0.0734 a year ago.